Molecular Weight
813.93 Da
Half-Life
10-15 minutes
Evidence Passport
Evidence strength, status, identity, route and safety are scored separately.
Human evidence
Human source linked; classification pending
A human source exists, but its strength and applicability have not completed review.
Development status
Status not verified
Investigational development is not the same as approval or product suitability.
Identity match
Named compound linked
Sources are linked to the named compound; formulation and product quality remain separate questions.
Route relevance
Route match not verified
Catalogue route: Intranasal spray. A matching human study route is not confirmed.
Safety record
4 documented flags
Documented flags are visible, but absence of a listed risk would not prove safety.
1 app-verified source linked · Version 2026-08-31
A synthetic heptapeptide comprising the ACTH (4-7) fragment with a C-terminal Pro-Gly-Pro tripeptide. Targets µ-opioid receptors, regulates USP18 and deubiquitination of FTO protein. Inhibits pyroptosis and decreases oxidative stress in neuronal cells. Modulates BDNF and enhances neuroplasticity.
These topics describe the catalogue's research index. They are not promised outcomes or personal recommendations.
Semax neuroprotective effects (2011)
Demonstrated significant neuroprotection in stroke models
DOI: 10.1007/s12035-011-8211-5Explore more peptides in this category
View All Cognitive Peptides →Research Disclaimer: This information is compiled from published research and is provided for educational purposes only. Peptides discussed here are classified as research chemicals in most jurisdictions and are not FDA-approved for human use unless otherwise noted. Consult a qualified healthcare provider before starting any protocol.